Skip to main content
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc.

Track CRVS — free
$14.39 -0.26 (-1.77%) At close · Sep 4
Market Cap
$1.19B
Shares
84.12M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type Filing Date Period Open
Showing 1–50 of 111 filings
Key facts CIK 1626971 CUSIP 221015100 13F (30d) 139 filings 139 filers Visit website Investor relations